Qi Deng

495 total citations
24 papers, 359 citations indexed

About

Qi Deng is a scholar working on Virology, Oncology and Molecular Biology. According to data from OpenAlex, Qi Deng has authored 24 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Qi Deng's work include HIV Research and Treatment (6 papers), Ubiquitin and proteasome pathways (4 papers) and Mathematical and Theoretical Epidemiology and Ecology Models (4 papers). Qi Deng is often cited by papers focused on HIV Research and Treatment (6 papers), Ubiquitin and proteasome pathways (4 papers) and Mathematical and Theoretical Epidemiology and Ecology Models (4 papers). Qi Deng collaborates with scholars based in China, United States and Canada. Qi Deng's co-authors include Cong Jiang, Tingting Niu, Peijun Wang, Xia Yang, Weijuan Pan, Xiaoyan Cai, Xinyu Wang, Meiling Lü, Ji‐An Pan and Jianru Xiao and has published in prestigious journals such as Oncogene, Radiology and Biochemical Pharmacology.

In The Last Decade

Qi Deng

23 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Deng China 9 235 103 53 48 47 24 359
María Piedad Fernández-Pérez Spain 12 202 0.9× 72 0.7× 99 1.9× 43 0.9× 79 1.7× 15 368
Shuangshuang Lu China 12 143 0.6× 133 1.3× 49 0.9× 46 1.0× 71 1.5× 31 338
Smita Misra United States 14 368 1.6× 129 1.3× 37 0.7× 67 1.4× 94 2.0× 31 569
Daniela De Martino Italy 12 198 0.8× 137 1.3× 71 1.3× 47 1.0× 66 1.4× 15 475
Hung Sing Li Hong Kong 9 111 0.5× 88 0.9× 53 1.0× 20 0.4× 55 1.2× 13 293
Souparno Bhattacharya United States 11 381 1.6× 133 1.3× 141 2.7× 48 1.0× 58 1.2× 13 573
Sharon Shechter United States 11 264 1.1× 63 0.6× 20 0.4× 25 0.5× 49 1.0× 22 372
Ziyong Sun China 13 207 0.9× 54 0.5× 23 0.4× 34 0.7× 96 2.0× 22 379
Heng Yang China 10 178 0.8× 186 1.8× 104 2.0× 33 0.7× 49 1.0× 16 389

Countries citing papers authored by Qi Deng

Since Specialization
Citations

This map shows the geographic impact of Qi Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Deng more than expected).

Fields of papers citing papers by Qi Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Deng. The network helps show where Qi Deng may publish in the future.

Co-authorship network of co-authors of Qi Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Deng. A scholar is included among the top collaborators of Qi Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Deng. Qi Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Qi, Ali Asgary, Jude Dzevela Kong, et al.. (2025). Uncovering the impact of infection routes on within-host MPXV dynamics: Insights from a mathematical modeling study. PLoS Computational Biology. 21(5). e1013073–e1013073. 1 indexed citations
2.
Deng, Qi, Jieyao Liu, Fangqin Lin, et al.. (2025). AXL enhances the self-renewal of cancer stem-like cells and Osimertinib chemoresistance by regulating SCD1 in non-small cell lung cancer. Biochemical Pharmacology. 240. 117067–117067. 1 indexed citations
3.
Deng, Qi, et al.. (2025). Modeling SARS-CoV-2 Infection Dynamics: Insights into Viral Clearance and Immune Synergy. Bulletin of Mathematical Biology. 87(6). 67–67.
4.
Deng, Qi, et al.. (2024). HIV infection dynamics with broadly neutralizing antibodies and CTL immune response. Discrete and Continuous Dynamical Systems - S. 18(12). 3631–3660. 3 indexed citations
5.
Deng, Qi, et al.. (2024). A mathematical model for HIV dynamics with multiple infections: implications for immune escape. Journal of Mathematical Biology. 89(1). 6–6. 4 indexed citations
6.
Deng, Qi, et al.. (2023). HIV infection dynamics and viral rebound: Modeling results from humanized mice. Journal of Theoretical Biology. 567. 111490–111490. 2 indexed citations
7.
Deng, Qi, et al.. (2023). Modeling the cytotoxicity of Romidepsin reveals the ineffectiveness of this drug in the “shock and kill” strategy. Chaos Solitons & Fractals. 173. 113702–113702. 3 indexed citations
8.
Deng, Qi, et al.. (2022). Towards a new combination therapy with vectored immunoprophylaxis for HIV: Modeling “shock and kill” strategy. Mathematical Biosciences. 355. 108954–108954. 11 indexed citations
9.
Mu, Juan, Meijing Liu, Jia Wang, et al.. (2022). Successful treatment of second-time CAR-T 19 therapy after failure of first-time CAR-T 19 and ibrutinib therapy in relapsed mantle cell lymphoma. Advances in Clinical and Experimental Medicine. 31(3). 327–335. 2 indexed citations
10.
11.
Zheng, Dandan, Yueyue Sun, Qi Deng, et al.. (2021). Preliminary therapeutic and mechanistic evaluation of S-allylmercapto-N-acetylcysteine in the treatment of pulmonary emphysema. International Immunopharmacology. 98. 107913–107913. 5 indexed citations
12.
Li, Na, et al.. (2021). Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 224. 113701–113701. 19 indexed citations
14.
Deng, Qi, et al.. (2020). Modeling within-host viral dynamics: The role of CTL immune responses in the evolution of drug resistance. Discrete and Continuous Dynamical Systems - B. 26(7). 3543–3562. 4 indexed citations
15.
Deng, Qi, et al.. (2017). MLN4924 protects against bleomycin-induced pulmonary fibrosis by inhibiting the early inflammatory process.. PubMed. 9(4). 1810–1821. 25 indexed citations
16.
Zhu, Liqin, et al.. (2016). Network Meta-analysis of efficacy of 3 kinds of Chinese medicine injections in preventing oxaliplatin-induced peripheral neurotoxicity in cancer patients. 36(18). 1571. 2 indexed citations
17.
Sun, Jinxia, Yi Luan, Xiao Tan, et al.. (2016). The 11S Proteasome Subunit PSME3 Is a Positive Feedforward Regulator of NF-κB and Important for Host Defense against Bacterial Pathogens. Cell Reports. 14(4). 737–749. 36 indexed citations
18.
Pan, Ji‐An, Qi Deng, Cong Jiang, et al.. (2014). USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene. 34(30). 3957–3967. 124 indexed citations
19.
Zhao, Nan, Mingfeng Zhao, Wenyi Lu, et al.. (2013). [Effects and mechanism on anti-leukemic activity of cytokine-induced killer cells with an endogenous expression of interleukin-21].. PubMed. 93(4). 293–9. 3 indexed citations
20.
Wang, Rui, Yan Wang, Ning Liu, et al.. (2013). FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation. Cell Research. 23(6). 803–819. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026